STOCK TITAN

Insider plans 881-share Rule 144 sale in FTRE (NASDAQ: FTRE)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

A holder of FTRE common stock filed a notice to sell 881 shares of common stock under Rule 144 through Fidelity Brokerage Services on or about February 10, 2026 on NASDAQ, with an aggregate market value of $12,230.22.

The 881 shares were acquired as restricted stock vesting from the issuer on February 9, 2026, treated as compensation. The notice states that the person selling the securities does not know of any material adverse, nonpublic information about the issuer’s current or prospective operations.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does FTRE’s latest Form 144 filing disclose?

The filing discloses a planned sale of 881 shares of FTRE common stock under Rule 144. The shares were recently acquired through restricted stock vesting and will be sold on the NASDAQ through Fidelity Brokerage Services.

How many FTRE shares are planned to be sold and at what value?

The notice covers a planned sale of 881 common shares of FTRE with an aggregate market value of $12,230.22. This gives an approximate indication of the total dollar size of the intended transaction.

When were the FTRE shares being sold under Rule 144 acquired?

The 881 FTRE common shares were acquired on February 9, 2026 through a restricted stock vesting transaction from the issuer. The filing identifies this vesting as compensation rather than a cash purchase.

When is the sale of FTRE shares under this Form 144 expected?

The planned sale date for the 881 FTRE common shares is listed as February 10, 2026. The securities are expected to be sold on the NASDAQ market through Fidelity Brokerage Services LLC as broker.

What representation does the selling holder make in FTRE’s Form 144?

The selling holder represents that they do not know any material adverse information about FTRE’s current or prospective operations that has not been publicly disclosed. This representation is made when signing the Form 144 notice.

How many FTRE shares are outstanding in this Form 144 notice?

The Form 144 lists 92,400,000 FTRE common shares as outstanding. This figure provides a baseline for the company’s overall share count relative to the 881 shares covered by the planned sale.
Fortrea Holdings

NASDAQ:FTRE

FTRE Rankings

FTRE Latest News

FTRE Latest SEC Filings

FTRE Stock Data

948.95M
91.88M
0.5%
111.46%
11.57%
Biotechnology
Services-medical Laboratories
Link
United States
DURHAM